Valion Bio Inc VBIO

US Health Care

$2.83 ▲ +4.81% (+$0.13)

📈 Near 52W High ⬆️ Above Yest. High ⚡ High Volume 🎈 Low Float

Open $2.63

Prev Close $2.70

Day Range $2.41 – $3.12

52W Range $2.05 – $32.50

Market Cap $2.51M

Beta 3.76

EPS (TTM) $-8.23

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-11-11
Shares Out.	4,150,000
Website	tivichealth.com ↗
Phone	3026365401
Employees	52
Revenue	$0
Gross Profit	$0
Net Income	-$7.1M
Free Cash Flow	-$14.7M
Total Assets	$32.5M
Total Liabilities	$20.6M
Equity	$4.2M

About Valion Bio Inc

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Valion Bio Inc is a publicly traded company under the ticker symbol VBIO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.